20 May 2013
Keywords: PharmaMar, Centocor Ortho, Yondelis, Zeltia, Sarcoma, Ovarian cancer
Article | 17 March 2010
Centocor Ortho Biotech Products, a Johnson & Johnson subsidiary that has licensed rights in certain markets for Yondelis (trabectedin) from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2010
16 March 2010
18 March 2010
© 2013 thepharmaletter.com